“Our findings demonstrate that CAR-NKT cells not only effectively eliminate CD1d-expressing M2-like macrophages within the tumor microenvironment but also stimulate endogenous immune cells ...
Our understanding of immunology has revolutionized cancer treatment ... a drug that activates the protective NKT cells. They observed that the mice had improved neurological outcomes.